相关实验视频
Updated: Mar 18, 2026

08:39
Murine Colitis Modeling using Dextran Sulfate Sodium DSS
Published on: January 19, 2010
51.3K
努江的Amomum tsaoko提取物通过抑制死细胞灭亡来缓解DSS诱导的大肠炎
Yuanyuan Wang1,2, Keyi Lu1,2, Yuhang Gong1,2
1Collaborative Innovation Center of Research and Development on The Whole Industry Chain of Yu-Yao, Henan Province, Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Frontiers in cell and developmental biology
|March 16, 2026
概括
曹国 (CG) 抑制亡,这是一个与性结肠炎 (UC) 相关的细胞死亡途径. 这种传统中医药改善了肠道屏障功能,减少了炎症,为UC患者提供了潜在的新疗法.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亡,一个被编程的细胞死亡,危害肠道屏障,并驱动性结肠炎 (UC) 的炎症.
- 曹国 (CG) 是一种传统的中医药,用于UC,但其活性化合物和机制尚不清楚.
研究的目的:
- 调查CG.的化学成分和抗死细胞灭绝活性.
- 在UC的小鼠模型中探索CG的治疗目标和疗效.
主要方法:
- 对CG的化学分析.
- 在体外亡模型来评估CG的抗亡作用.
- 用于验证的UC的鼠标模型.
- 生物信息学分析和治疗点的实验验证.
主要成果:
- 在体外,CG抑制了RIPK1,RIPK3和MLKL的酸化.
- 在UC小鼠中,CG治疗改善了体重,减少了疾病活性,并增强了肠道屏障功能.
- 在体内,CG下调化RIPK3和MLKL表达.
- 生物信息学建议CG通过STAT3途径起作用,这一点得到了实验支持.
结论:
- CG显示出显著的抗死细胞灭绝活性.
- 通过抑制亡并可能调节STAT3通路,CG可以改善UC.
- CG代表了性结肠炎的有前途的治疗药物.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
849
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
849
Drugs for Treatment of Ulcerative Colitis in IBD
596
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
596

